These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18183577)

  • 21. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.
    Kong B; Wang Q; Fung E; Xue K; Tsang BK
    J Biol Chem; 2014 Sep; 289(39):27134-27145. PubMed ID: 25112877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.
    Feng Q; Li P; Salamanca C; Huntsman D; Leung PC; Auersperg N
    Cancer Res; 2005 Oct; 65(19):8591-6. PubMed ID: 16204022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
    Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
    Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.
    Chen Y; Mu X; Wang S; Zhao L; Wu Y; Li J; Li M
    Oncol Rep; 2013 Jan; 29(1):288-96. PubMed ID: 23129262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
    Peng B; Chang Q; Wang L; Hu Q; Wang Y; Tang J; Liu X
    Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer.
    Ruan M; Liu M; Dong Q; Chen L
    J Clin Endocrinol Metab; 2015 May; 100(5):1771-9. PubMed ID: 25768669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG.
    Chen XP; Chen YG; Lan JY; Shen ZJ
    Cancer Lett; 2014 Oct; 353(2):201-10. PubMed ID: 25063739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.
    Han Z; Feng J; Hong Z; Chen L; Li W; Liao S; Wang X; Ji T; Wang S; Ma D; Chen G; Gao Q
    Biochem Biophys Res Commun; 2013 May; 435(2):188-94. PubMed ID: 23665025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
    Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q
    Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch3-specific inhibition using siRNA knockdown or GSI sensitizes paclitaxel-resistant ovarian cancer cells.
    Kang H; Jeong JY; Song JY; Kim TH; Kim G; Huh JH; Kwon AY; Jung SG; An HJ
    Mol Carcinog; 2016 Jul; 55(7):1196-209. PubMed ID: 26207830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.
    Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F
    Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
    Tsai SC; Lu CC; Lee CY; Lin YC; Chung JG; Kuo SC; Amagaya S; Chen FN; Chen MY; Chan SF; Yang JS
    Int J Oncol; 2012 Nov; 41(5):1683-92. PubMed ID: 22922805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prohibitin 1 gene delivery promotes functional recovery in rats with spinal cord injury.
    Li L; Guo JD; Wang HD; Shi YM; Yuan YL; Hou SX
    Neuroscience; 2015 Feb; 286():27-36. PubMed ID: 25463519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.
    Zeybek ND; Gulcelik NE; Kaymaz FF; Sarisozen C; Vural I; Bodur E; Canpinar H; Usman A; Asan E
    J Endocrinol; 2011 Jul; 210(1):105-15. PubMed ID: 21478229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staurosporine induces apoptosis in human papillomavirus positive oral cancer cells at G2/M phase by disrupting mitochondrial membrane potential and modulation of cell cytoskeleton.
    Sarkar J; Singh N; Meena S; Sinha S
    Oral Oncol; 2009 Nov; 45(11):974-9. PubMed ID: 19502099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer.
    Wei L; Xue T; Wang J; Chen B; Lei Y; Huang Y; Wang H; Xin X
    Int J Cancer; 2009 Aug; 125(4):791-806. PubMed ID: 19391138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.